{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:36:47Z","timestamp":1761975407500},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Immunol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2172-15-26","type":"journal-article","created":{"date-parts":[[2014,6,21]],"date-time":"2014-06-21T23:02:39Z","timestamp":1403391759000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study"],"prefix":"10.1186","volume":"15","author":[{"given":"Fernanda Aim\u00e9e","family":"Nobre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela Garrido da Silva","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel Maria","family":"Sim\u00e3o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Isabel","family":"de Moraes Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz Tavares","family":"Costa-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,21]]},"reference":[{"issue":"2","key":"583_CR1","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.iac.2008.01.008","volume":"28","author":"M Berger","year":"2008","unstructured":"Berger M: Principles of and advances in immunoglobulin replacement therapy for primary immunodeficiency. Immunol Allergy Clin North Am. 2008, 28 (2): 413-437.","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"583_CR2","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ijantimicag.2010.11.027","volume":"37","author":"LJ Maarschalk-Ellerbroek","year":"2011","unstructured":"Maarschalk-Ellerbroek LJ, Hoepelman IM, Ellerbroek PM: Immunoglobulin treatment in primary antibody deficiency. Int J Antimicrob Agents. 2011, 37 (5): 396-404.","journal-title":"Int J Antimicrob Agents"},{"issue":"4","key":"583_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.intimp.2005.11.003","volume":"6","author":"EW Gelfang","year":"2006","unstructured":"Gelfang EW: Differences between IGIV products: impact on clinical outcome. Int Immunopharmacol. 2006, 6 (4): 592-599.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"583_CR4","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.jaci.2007.11.001","volume":"121","author":"D Lejtenyi","year":"2008","unstructured":"Lejtenyi D, Mazer B: Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations. J Allergy Clin Immunol. 2008, 121 (1): 254-255.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"583_CR5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/CDLI.11.6.1158-1164.2004","volume":"11","author":"MG Mikolajczyk","year":"2004","unstructured":"Mikolajczyk MG, Concepcion NF, Wang T, Frazier D, Golding B, Frasch CE, Scott DE: Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenza type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Clin Diagn Lab Immunol. 2004, 11 (6): 1158-1164.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"6","key":"583_CR6","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1086\/506363","volume":"194","author":"S Audet","year":"2006","unstructured":"Audet S, Virata-Theimer ML, Beeler JA, Scott DE, Frazier DJ, Mikolajczk MG, Eller N, Chen FM, Yu MY: Measles-virus-neutralizing antibodies in intravenous immunoglobulins. J Infect Dis. 2006, 194 (6): 781-789.","journal-title":"J Infect Dis"},{"issue":"1","key":"583_CR7","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jaci.2009.09.008","volume":"125","author":"MR Farcet","year":"2010","unstructured":"Farcet MR, Planitzer CB, Stein O, Modrof J, Kreil TR: Hepatitis A virus antibodies in immunoglobulin preparations. J Allergy Clin Immunol. 2010, 125 (1): 198-202.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"583_CR8","doi-asserted-by":"publisher","first-page":"e484","DOI":"10.1542\/peds.2009-0047","volume":"124","author":"AM Maranich","year":"2009","unstructured":"Maranich AM, Rajnik M: Varicella-specific immunoglobulin G titers in commercial intravenous immunoglobulin preparations. Pediatrics. 2009, 124 (3): e484-e488.","journal-title":"Pediatrics"},{"issue":"3","key":"583_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s10875-011-9511-0","volume":"31","author":"I Quinti","year":"2011","unstructured":"Quinti I, Soresina A, Guerra A, Rondelli R, Spadaro G, Agostini C, Milito C, Trombetta AC, Visentini M, Martini H, Plebani A, Fiorilli M, IPINet Investigators: Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol. 2011, 31 (3): 315-322.","journal-title":"J Clin Immunol"},{"issue":"6","key":"583_CR10","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","volume":"125","author":"M Lucas","year":"2010","unstructured":"Lucas M, Lee M, Lortan J, Lopez-Granados E, Misbah S, Chapel H: Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years. J Allergy Clin Immunol. 2010, 125 (6): 1354-1360.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"583_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","volume":"137","author":"JS Orange","year":"2010","unstructured":"Orange JS, Grossman WJ, Navickis RJ, Wilkes MM: Impact of trough IgG on pneumonia incidencein primary immunodeficiency: A meta-analysis of clinical studies. Clin Immunol. 2010, 137 (1): 21-30.","journal-title":"Clin Immunol"},{"issue":"2","key":"583_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0928-8244(03)00304-3","volume":"40","author":"A Aghamohammadi","year":"2004","unstructured":"Aghamohammadi A, Moin M, Farhoudi A, Rezaei N, Pourpak Z, Movahedi M, Gharagozlow M, Nabavi M, Shahrokhi A: Efficacy of intravenous immunoglobulin on the prevention of pneumonia in patients with agammaglobulinemia. FEMS Immunol Med Microbiol. 2004, 40 (2): 113-118.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"6","key":"583_CR13","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1067\/mai.2002.124999","volume":"109","author":"PJ Busse","year":"2002","unstructured":"Busse PJ, Razvi S, Cunningham-Rundles C: Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency. J Allergy Clin Immunol. 2002, 109 (6): 1001-1004.","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"583_CR14","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1542\/peds.2008-3645","volume":"124","author":"ME Pichichero","year":"2009","unstructured":"Pichichero ME: Booster vaccinations: can immunologic memory outpace disease pathogenesis?. Pediatrics. 2009, 124 (6): 1633-1641.","journal-title":"Pediatrics"},{"issue":"1","key":"583_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.jaci.2008.04.044","volume":"122","author":"VR Bonagura","year":"2008","unstructured":"Bonagura VR, Marchlewski R, Cox A, Rosenthal DW: Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection. J Allergy Clin Immunol. 2008, 122 (1): 210-211.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"583_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.clim.2011.02.020","volume":"139","author":"FA Bonilla","year":"2011","unstructured":"Bonilla FA: IgG replacement therapy, no size fits all. Clin Immunol. 2011, 139 (2): 107-109.","journal-title":"Clin Immunol"},{"issue":"6","key":"583_CR17","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.jaci.2011.01.035","volume":"127","author":"I Chua","year":"2011","unstructured":"Chua I, Lagos M, Charalambous BM, Workman S, Chee R, Grimbacher B: Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG. J Allergy Clin Immunol. 2011, 127 (6): 1410-1411.","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"583_CR18","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/j.1699-0463.1997.tb05093.x","volume":"105","author":"M Kristiansen","year":"1997","unstructured":"Kristiansen M, Aggerbeck H, Heron I: Improved ELISA for determination of anti-diphtheria and\/or anti-tetanus antitoxin antibodies in sera. APMIS. 1997, 105 (11): 843-853.","journal-title":"APMIS"},{"issue":"3","key":"583_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1590\/S0036-46652004000300008","volume":"46","author":"E Ono","year":"2004","unstructured":"Ono E, Lafer MM, Weckx LY, Granato C, de Moraes-Pinto MI: A Simple and cheaper in house varicella zoster virus antibody indirect ELISA. Rev Inst Med Trop Sao Paulo. 2004, 46 (3): 165-168.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"5","key":"583_CR20","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","volume":"162","author":"RT Chen","year":"1990","unstructured":"Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA: Measles antibody: reevaluation of protective titers. J Infect Dis. 1990, 162 (5): 1036-1042.","journal-title":"J Infect Dis"},{"issue":"2","key":"583_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jcv.2006.01.017","volume":"36","author":"F de Ory","year":"2006","unstructured":"de Ory F, Echevarr\u00eda JM, Kafatos G, Anastassopoulou C, Andrews N, Backhouse J, Berbers G, Bruckova B, Cohen DI, de Melker H, Davidkin I, Gabutti G, Hesketh LM, Johansen K, Jokinen S, Jones L, Linde A, Miller E, Mossong J, Nardone A, Rota MC, Sauerbrei A, Schneider F, Smetana Z, Tischer A, Tsakris A, Vranckx R: European seroepidemiology network 2: Standardisation of assays for seroepidemiology of varicella zoster virus. J Clin Virol. 2006, 36 (2): 111-118.","journal-title":"J Clin Virol"}],"container-title":["BMC Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2172-15-26.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T07:13:19Z","timestamp":1597993999000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcimmunol.biomedcentral.com\/articles\/10.1186\/1471-2172-15-26"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,21]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["583"],"URL":"https:\/\/doi.org\/10.1186\/1471-2172-15-26","relation":{},"ISSN":["1471-2172"],"issn-type":[{"value":"1471-2172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,21]]},"assertion":[{"value":"31 January 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"26"}}